title: Extreme hypereosinophilia, Churg-Strauss syndrome and mononeuritis multiplex.
authors.affiliation: Department of Neurology, Cleveland Clinic, Cleveland, OH 44195, USA. johns@ccf.org
authors.forename: Seby
authors.initials: S
authors.lastname: John
authors.forename: Ashwini
authors.initials: A
authors.lastname: Mhatre
authors.forename: Matthew P
authors.initials: MP
authors.lastname: Bunyard
authors.forename: Jinny
authors.initials: J
authors.lastname: Tavee
mesh_terms: D018501:Antirheumatic Agents / Q000627:therapeutic use; D015267:Churg-Strauss Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D015897:Comorbidity; D003520:Cyclophosphamide / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D017681:Hypereosinophilic Syndrome / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D020422:Mononeuropathies / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology*; D011241:Prednisone / Q000627:therapeutic use; D012720:Severity of Illness Index; D016896:Treatment Outcome
chemical_list: D018501:Antirheumatic Agents; D005938:Glucocorticoids; D003520:Cyclophosphamide; D011241:Prednisone; D008775:Methylprednisolone